SynaptixBio

TUBB4A-associated leukodystrophy

Dr Dan Williams, CEO and Co-Founder of new biotech business SynaptixBio, discusses how the search is on to find the first treatment for...

Business digest C&I Issue 11, 2021

SynaptixBio, an Oxford, UK-based research company, has been launched by a worldwide team of medical and pharmaceutical scientists to...

New biotech firm launched to develop ‘revolutionary’ treatment for one of world’s rarest diseases

A new biotech business SynaptixBio has been launched to tackle one of the world’s rarest neurodegenerative diseases. SynaptixBio is...

Oxford Biotech Firm Launches To Tackle Rare Disease – Insider Limited

A biotech business has launched in Oxford in a bid to tackle one of the world’s rarest diseases. SynaptixBio is working to develop a...

Oxford biotech firm launches to tackle rare disease

A biotech business has launched in Oxford in a bid to tackle one of the world's rarest diseases. SynaptixBio is working to develop a...

SynaptixBio launched with singular focus

A new biotech company has been launched with the goal of taking on one of the world’s rarest neurodegenerative… To continue reading...

Danish biotech profile is helping to establish its fourth company abroad

Bent Jakobsen, who has previously co-founded three biotech companies abroad, is now helping to establish his fourth of its kind,...

Synaptixbio sets off on quest to find therapy for rare CNS disease

U.K.’s Synaptixbio Ltd. has launched, aiming to tackle a rare and often fatal disease of the central nervous system (CNS), TUBB4a...

Oxford biotech firm SynaptixBio launched to develop ‘revolutionary’ treatment

A new biotech business has been launched in Oxford to tackle one of the world’s rarest diseases. SynaptixBio is working to develop the...

Biotech to develop treatment for neurodegenerative disease

A team of medical and pharmaceutical experts has founded SynaptixBio, an Oxford-based research company working to develop the world’s...

This week in drug discovery (18-22 October)

News round-up by DDW’s Megan Thomas for 18-22 October DDW’s Megan Thomas has selected five stories which highlight the opportunities in...

SynaptixBio Formed to Tackle One of the World’s Rarest Diseases

SynaptixBio CEO and Co-Founder Dan Williams/Courtesy SynaptixBio TUBB4a-related leukodystrophy is considered one of the rarest diseases...